These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 14726653

  • 1. Differential effects of selective COX-2 inhibitors on cell cycle regulation and proliferation of glioblastoma cell lines.
    Kardosh A, Blumenthal M, Wang WJ, Chen TC, Schönthal AH.
    Cancer Biol Ther; 2004 Jan; 3(1):55-62. PubMed ID: 14726653
    [Abstract] [Full Text] [Related]

  • 2. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S, Tegeder I, Niederberger E, Bräutigam L, Geisslinger G.
    FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
    [Abstract] [Full Text] [Related]

  • 3. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS, Davis TW, Ornberg RL, Masferrer JL.
    Cancer Res; 2002 Nov 15; 62(22):6706-11. PubMed ID: 12438270
    [Abstract] [Full Text] [Related]

  • 4. Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation.
    Pinheiro RM, Calixto JB.
    Inflamm Res; 2002 Dec 15; 51(12):603-10. PubMed ID: 12558194
    [Abstract] [Full Text] [Related]

  • 5. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S, Urade M, Nishimura N, Maeda T, Takaoka K, Noguchi K, Sakurai K.
    Int J Oncol; 2003 Sep 15; 23(3):665-72. PubMed ID: 12888902
    [Abstract] [Full Text] [Related]

  • 6. Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells.
    Niederberger E, Manderscheid C, Grösch S, Schmidt H, Ehnert C, Geisslinger G.
    Biochem Pharmacol; 2004 Jul 15; 68(2):341-50. PubMed ID: 15194006
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Yasumaru M, Tsuji S, Tsujii M, Irie T, Komori M, Kimura A, Nishida T, Kakiuchi Y, Kawai N, Murata H, Horimoto M, Sasaki Y, Hayashi N, Kawano S, Hori M.
    Cancer Res; 2003 Oct 15; 63(20):6726-34. PubMed ID: 14583467
    [Abstract] [Full Text] [Related]

  • 8. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.
    Patel MI, Subbaramaiah K, Du B, Chang M, Yang P, Newman RA, Cordon-Cardo C, Thaler HT, Dannenberg AJ.
    Clin Cancer Res; 2005 Mar 01; 11(5):1999-2007. PubMed ID: 15756026
    [Abstract] [Full Text] [Related]

  • 9. COX-2-Specific inhibitors--the emergence of a new class of analgesic and anti-inflammatory drugs.
    Everts B, Währborg P, Hedner T.
    Clin Rheumatol; 2000 Mar 01; 19(5):331-43. PubMed ID: 11055820
    [Abstract] [Full Text] [Related]

  • 10. First and second generations of COX-2 selective inhibitors.
    de Leval X, Julémont F, Benoit V, Frederich M, Pirotte B, Dogné JM.
    Mini Rev Med Chem; 2004 Aug 01; 4(6):597-601. PubMed ID: 15279593
    [Abstract] [Full Text] [Related]

  • 11. Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models.
    Palomer A, Cabré F, Pascual J, Campos J, Trujillo MA, Entrena A, Gallo MA, García L, Mauleón D, Espinosa A.
    J Med Chem; 2002 Mar 28; 45(7):1402-11. PubMed ID: 11906281
    [Abstract] [Full Text] [Related]

  • 12. A new class of COX-2 inhibitors offer an alternative to NSAIDS in pain management after spinal surgery.
    Reuben SS.
    Spine (Phila Pa 1976); 2001 Jul 01; 26(13):1505-6. PubMed ID: 11458162
    [No Abstract] [Full Text] [Related]

  • 13. Modulation of cyclooxygenase-2 activities by the combined action of celecoxib and decosahexaenoic acid: novel strategies for colon cancer prevention and treatment.
    Swamy MV, Cooma I, Patlolla JM, Simi B, Reddy BS, Rao CV.
    Mol Cancer Ther; 2004 Feb 01; 3(2):215-21. PubMed ID: 14985462
    [Abstract] [Full Text] [Related]

  • 14. Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer.
    Fu SL, Wu YL, Zhang YP, Qiao MM, Chen Y.
    World J Gastroenterol; 2004 Jul 01; 10(13):1971-4. PubMed ID: 15222049
    [Abstract] [Full Text] [Related]

  • 15. COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells.
    Majchrzak-Celińska A, Misiorek JO, Kruhlenia N, Przybyl L, Kleszcz R, Rolle K, Krajka-Kuźniak V.
    BMC Cancer; 2021 May 03; 21(1):493. PubMed ID: 33941107
    [Abstract] [Full Text] [Related]

  • 16. Effects of NSAIDs on proliferation of gastric cancer cells in vitro: possible implication of cyclooxygenase-2 in cancer development.
    Sawaoka H, Kawano S, Tsuji S, Tsujii M, Murata H, Hori M.
    J Clin Gastroenterol; 1998 May 03; 27 Suppl 1():S47-52. PubMed ID: 9872498
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma.
    Badawi AF, Eldeen MB, Liu Y, Ross EA, Badr MZ.
    Cancer Res; 2004 Feb 01; 64(3):1181-9. PubMed ID: 14871855
    [Abstract] [Full Text] [Related]

  • 18. COX-2 inhibitors.
    Hawkey CJ.
    Lancet; 1999 Jan 23; 353(9149):307-14. PubMed ID: 9929039
    [Abstract] [Full Text] [Related]

  • 19. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors.
    Kusunoki N, Yamazaki R, Kawai S.
    Arthritis Rheum; 2002 Dec 23; 46(12):3159-67. PubMed ID: 12483719
    [Abstract] [Full Text] [Related]

  • 20. The new NSAIDs: cox-2 inhibitors.
    Capriotti T.
    Medsurg Nurs; 2000 Dec 23; 9(6):313-7. PubMed ID: 11904867
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.